Incidence and risk of hepatic toxicities associated with anaplastic lymphoma kinase inhibitors in the treatment of non-small-cell lung cancer: a systematic review and meta-analysis
2020 ◽
Vol 45
(4)
◽
pp. 743-754
◽
2019 ◽
Vol 213
(5)
◽
pp. 1059-1072
◽
2017 ◽
Vol 18
(4)
◽
pp. e251-e258
◽
2020 ◽
Vol 21
(8)
◽
pp. 931-940
◽
2016 ◽
Vol 16
(8)
◽
pp. 877-883
2018 ◽
2016 ◽
Vol 17
(6)
◽
pp. 739-745
◽
2018 ◽
Vol 58
(4)
◽
pp. 403-420
◽
2017 ◽
Vol 9
(S13)
◽
pp. S1391-S1396
◽